This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Biothera announced today that it has initiated enrollment of patients in a phase Ib/IIa clinical trial to evaluate the safety and efficacy of Imprime PGG(TM) and Erbitux(R) in patients with metastatic colorectal cancer.
We care about your feedback. Let us know how we can improve your CancerCompass experience.